However, an equivalent assessment of liver fibrosis in the HSA-Trx group corresponded to stage 0–1, indicating that the clinical goal for liver fibrosis could be achieved (Fig. 2G-L). This evidence concerns the gene TXN and Hepatic fibrosis.